심부전 및 쇼크 환자의 약물요법

참고문헌 (22)

1. Youngberg JA, "Cardiac, vascular and thoracic anesthesia", pp.436~465 (2000), Churchill Livingstone
2. Bristow MR, "Decreased catecholamine sensitivity and B-adrenergic-receptor density in failing human hearts", N Engl J Med, 307, pp.205~211 (1982)
3. Brodde OE, "Regional distribution of β-adrenoceptors in the human heart: coexistence of function of β1-and β2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy", J Cardiovasc Pharmacol, 8, pp.1235~1242 (1986)
4. Kontoyannis DA, "Severe cardiogenic shock, after cardioversion, reversed by the intraaortic balloon pump", Intensive Care Med, 26, pp.649~ (2000)
5. Tempe DK, "Pharmacologic support of circulation in patients undergoing cardiac surgery", J Indian Med Assoc, 97, pp.411~418 (1999)
6. Majerus TC, "Dobutamine: ten years later", Pharmacotherapy, 9, pp.245~259 (1989)
7. Fitton A, "Dopexamine hydrochloride: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute cardiac insufficiency", Drugs, 39, pp.308~330 (1990)
8. Siostrzonek P, "Milrinone therapy in catecholamine-dependent critically ill patients with heart failure", Acta Anaesthesiol Scand, 44, pp.403~409 (2000)
9. Alousi AA, "Pharmacology of the bipyridines:amrinone and milrinone", Circulation, 73, pp.11110~11124 (1986)
10. Royster RL, "Combined inotropic effects of amrinone and epinephrine after cardiopulmonary bypass in humans", Anesth Analg, 77, pp.662~672 (1993)
11. Shipley JB, "Milrinone: basic and clinical pharmacology and acute and chronic management", Am J Med Sci, 311, pp.286~291 (1996)
12. Baruch L, "Pharmacodynamic effects of milrinone with and without a bolus loading infusion", Am Hear J, 141, pp.266~273 (2001)
13. Taniguchi T, "Pharmacokinetics of milrinone in patients with congestive heart failure during continuous venovenous hemofiltration", Intensive Care Med, 26, pp.1089~1093 (2000)
14. Baughman KL, "B-type natriuretic peptide: a window to the heart", N Engl J Med, 347, pp.158~159 (2002)
15. Lewis J, "Atrial natriuretic factor in oliguric acute renal failure", Am J Kidney Dis, 36, pp.767~774 (2000)
16. McCullough PA, "B-type natriuretic peptides: a diagnostic breakthrough for clinicians", Rev Cardiovasc Med, 4, pp.72~80 (2003)
17. Abraham WT, "Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure", J Card Fail, 4, pp.37~44 (1998)
18. Sackner-Bernstein JD, "Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure", Circulation, 111, pp.1487~1491 (2005)
19. Landry DW, "Vasopressin pressor hypersensitivity in vasodilatory septic shock", Crit Care Med, 25, pp.1279~1282 (1997)
20. Landry DW, "The pathogenesis of vasodilatory shock", N Engl J Med, 345, pp.588~595 (2001)
21. Landry DW, "Vasopressin deficiency contributes to the vasodilation of septic shock", Circulation, 95, pp.1122~1125 (1997)
22. Gold J, "Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure", Am J Cardiol, 85, pp.506~508 (2000)

관련 논문AI추천